Works matching IS 17597706 AND DT 2025 AND VI 16 AND IP 4

Results: 11

NSE and ProGRP Are Promising Markers for Diagnosis, Efficacy Evaluation, Follow‐Up Monitoring, and Prognosis of Small Cell Esophageal Carcinoma.

Published in:

Thoracic Cancer, 2025, v. 16, n. 4, p. 1, doi. 10.1111/1759-7714.70026

By:

Liu, Di;
Wu, Dan;
Ni, Jianjiao;
Zhang, Junhua;
Xie, Suhong

Publication type:

Article

A Novel DNA Repair‐Gene Model to Predict Responses to Immunotherapy and Prognosis in Patients With EGFR‐Mutant Non‐Small Cell Lung Cancer.

Published in:

Thoracic Cancer, 2025, v. 16, n. 4, p. 1, doi. 10.1111/1759-7714.70025

By:

Wang, Fen;
Wei, Xue‐Wu;
Yang, Ming‐Yi;
Lu, Chang;
Yang, Xiao‐Rong;
Deng, Jia‐Yi;
Chen, Zhi‐Hong;
Zhou, Qing

Publication type:

Article

METTL3/IGF2BP2 Promotes the Malignant Progression of Esophageal Cancer by Activating the PIK3CA/AKT Pathway.

Published in:

Thoracic Cancer, 2025, v. 16, n. 4, p. 1, doi. 10.1111/1759-7714.70022

By:

Guo, Xinmeng;
Huang, Anqi;
Qi, Ya'nan;
Chen, Jiaqi;
Yang, Meng;
Jin, Mulan

Publication type:

Article

Postoperative Adjuvant Therapy Benefits Non‐pCR Patients Rather Than pCR Patients for Locally Advanced ESCC: A Multicenter Real‐World Study.

Published in:

Thoracic Cancer, 2025, v. 16, n. 4, p. 1, doi. 10.1111/1759-7714.70021

By:

Liu, Defeng;
Liu, Ao;
Guo, Longxiang;
Li, Yi;
Li, Yuanlin;
Chi, Yuxiang;
Lin, Haiqun;
Yu, Jinming;
Li, Minghuan

Publication type:

Article

Perioperative Treatment in EGFR‐Mutant Early‐Stage Non‐Small Cell Lung Cancer: Current Evidence and Future Perspectives.

Published in:

Thoracic Cancer, 2025, v. 16, n. 4, p. 1, doi. 10.1111/1759-7714.70018

By:

Guo, Xiaobei;
Liu, Xiaoyan;
Guo, Chao;
Miao, Qian;
Cheng, Xinghua;
Hong, Xuan;
Li, Hongru;
Qiu, Xiaoming;
Xiang, Yi;
Zheng, Di;
Zhou, Jian;
Jiang, Liyan;
Xu, Yan;
Wang, Mengzhao

Publication type:

Article

Exploring the Clinical Value of Perioperative ctDNA‐Based Detection of Molecular Residual Disease in Patients With Esophageal Squamous Cell Carcinoma.

Published in:

Thoracic Cancer, 2025, v. 16, n. 4, p. 1, doi. 10.1111/1759-7714.70017

By:

Li, Jimin;
Wu, Congcong;
Song, Yongming;
Fan, Yuhui;
Li, Chao;
Li, Haibo;
Zhang, Shuangping

Publication type:

Article

A Comprehensive Analysis of FGF/FGFR Signaling Alteration in NSCLC: Implications in Prognosis and Microenvironment.

Published in:

Thoracic Cancer, 2025, v. 16, n. 4, p. 1, doi. 10.1111/1759-7714.70016

By:

Huang, Ziling;
Li, Leyao;
Cai, Xu;
Wang, Shen;
Jia, Yun;
Li, Yuan

Publication type:

Article

RETRACTION: Manganese‐12 Acetate Suppresses the Migration, Invasion, and Epithelial–Mesenchymal Transition by Inhibiting Wnt/β‐Catenin and PI3K/AKT Signaling Pathways in Breast Cancer Cells.

Published in:: Thoracic Cancer, 2025, v. 16, n. 4, p. 1, doi. 10.1111/1759-7714.70015
Publication type:: Article

Comparison of Various GAN‐Based Bone Suppression Imaging for High‐Accurate Markerless Motion Tracking of Lung Tumors in CyberKnife Treatment.

Published in:

Thoracic Cancer, 2025, v. 16, n. 4, p. 1, doi. 10.1111/1759-7714.70014

By:

Mochizuki, Zennosuke;
Saito, Masahide;
Suzuki, Toshihiro;
Mochizuki, Koji;
Nemoto, Hikaru;
Onishi, Hiroshi;
Takahashi, Hiroshi

Publication type:

Article

HOXA5 Derives the Malignant Progression and Cisplatin Resistance of Esophageal Squamous Cell Carcinoma by Regulating USP18‐Mediated IFI27 Deubiquitination.

Published in:

Thoracic Cancer, 2025, v. 16, n. 4, p. 1, doi. 10.1111/1759-7714.70013

By:

Wang, Qiang;
Ren, Shiheng;
Pan, Zheng;
Chen, Yuxin;
Liu, Xiangyan

Publication type:

Article

Issue Information.

Published in:: Thoracic Cancer, 2025, v. 16, n. 4, p. 1, doi. 10.1111/1759-7714.15342
Publication type:: Article